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In Keun Lee et al to represent a physician's knowledge and to support clinical decision making. In particular, FCMs [2, [8] [9] [10] [11] [12] [13] can efficiently handle complex modeling problems when assessing clinical decision making tasks [2] . FCMs represent causal knowledge between events and are used as tools that can predict results for current states of events by inference. FCMs have been used in not only clinical decision making but also system control, game theory, information analysis, etc. [10] . The advantages of FCMs are that FCMs can be represented in a matrix form and their inference process involves numerical matrix computations. During the inference process, the value of nodes in FCMs could be out of the range of [0, 1]; therefore, activation functions are used to keep the value of the nodes within the range. Therefore, the activation function used for the inference of FCMs is an important factor in determining the results of the inference.
Several research efforts have been conducted on activation functions for the inference process of FCMs [12] [13] [14] where a sigmoid function, hyperbolic tangent function, step function, and threshold linear function have been considered as activation functions, and [13] showed that the sigmoid function offers significantly greater advantages than the other functions. Moreover, Lee and Kwon [12] suggested a method for determining the λ value of a sigmoid function, as shown in Equation (1) , to design an activation function that adapts to an FCM model. 
During inference, the concept values of FCMs are restricted to v∈(0, 1) by the sigmoid function. One of the characteristics of a sigmoid function is that its domain is ( −∞ , ∞ ), whereas the range of the function is (0, 1), i.e., we cannot obtain a "0" or "1" as a concept value after inference. Moreover, while a sigmoid function using λ = 5 [13] is known to be a good degree for normalization in [0, 1] , the slope of a function of around x = 0 is greatly different from that of x = 1. Therefore, a sigmoid function is not suitable for use as a normalization function. As shown in Figure 1 , the sinusoidal-type function shown in Equation (2) βπ βπ − , and therefore, we can obtain "0" and "1" as the concept values after inference.
( )
Therefore, in this paper, we propose a method for designing activation functions for the inference of FCMs, which is different from the method suggested in [12] . Moreover, we apply the designed function to a clinical decision regarding the prediction of a pulmonary infection model [2] .
II. Methods

Model Description and Preliminaries
For convenience, we will use the following notations and definitions throughout this paper.
Notations. N, R ,
n R , and n m × R denote a set of natural numbers, a real number space, a real n-space, and a set of real n m × matrices, respectively. The superscript "T" denotes a vector and matrix transposition (i.e., if
where 1 i n ≤ ≤ , 1 j m ≤ ≤ , and , n m∈N ). For all n ∈ u R , let || || u denote the Euclidean vector norm (i.e.,
A denote the spectral norm (i.e., || || A = (the maximum eigenvalue of
is a state vector of a system, then v ∈ represents the value of j C at the k -th iteration step. Moreover, : f → R R is an activation function to restrict
Equation (4) is also represented in vector form as ( )
where
, where 1 , i j n ≤ ≤ , and are called a state vector and weight matrix, respectively. Moreover,
As in [12] , we transform the model from Equations. (4) and (5) into the form described in the following definition.
Definition 3 (Transformation). (refer to [12] ) For every j N ∈ and all 0 k ≥ , let ( )
in Equation (4); then,
We also consider unipolar, nonlinear, and continuous functions as activation functions of FCMs. Therefore, we assume that the activation functions satisfy the following conditions:
f → R R satisfies the Lipschitz condition with a Lipschitz constant, 0 L > ; i.e.,
Lee and Kwon [12] suggested a bound of L of activation functions satisfying Assumptions 1 and 2, as shown in Equation (7), which guarantees the global exponential stability of Equation (5) during an inference process of an FCM.
Moreover, as shown in Equation (8), the bound of λ was derived using Equation (7) and the property in which the maximum value of the derivative of a sigmoid function occurs when x = 0.
Consequently, the λ value are determined by adapting the weight matrix w as an FCM model and the sigmoid function whose λ value satisfies inequality (8) guarantees the stability of Equation (5).
Design of Sinusoidal-Type Activation Functions
As mentioned in the introduction, a sinusoidal-type function may not be appropriate to an activation function because it is oscillated in the bound of domain ( −∞ , ∞ ). From another viewpoint, the sinusoidal-type function, shown in Equation
βπ βπ − , could be better than a sigmoid function as a normalization function, because a sinusoidal-type function is a monotonous increase function that has a gentler slope than a sigmoid function does. Also, the range of a sinusoidal-type function is [0, 1], which is different than a sigmoid function whose range is (0, 1). Therefore, we need to find the value of β . Intuitively, /2 βπ and /2 βπ − may be the maximum and minimum values that x can reach during inference, respectively. Consequently, finding the maximum and minimum values of x is a way to find the value of β . Since a sinusoidal-type function will be used as an activation function for Equation (5) in this paper, the domain values will be the elements of vector ( ) k v in Definition 3. To find the bound of ( ) k x as the result of inference of an FCM using Equation (5), we give following lemmas.
Lemma 1. Let ( ) k
x and M be the same as in Definitions 3 and Assumption 1, respectively. Then, for all 0 k ≥ , the following inequality is satisfied.
Proof. Let the right term of inequality (6) be ( ) x ϕ as follows:
If we use the Euclidean norm for both terms of Equation (10), we can then derive the following inequality. www.e-hir.org 
If we suppose there exists (11) is represented as Equation (9) because of
be the same as in Definition
Proof. Consider a vector
. He re ,
i s t h e m a x i mu m a b s o lut e value among other elements within the unit circle in the vector norm. Thus, from inequality (11), we have ( )
We can know the domain range of a sinusoidal-type activation function used in the inference process of FCMs through Lemmas 1 and 2. Therefore, we give following theorem for the design of the sinusoidal-type activation function. ( ) (
x is the j -th element of ( ) k x , by Lemma 2 we know the range of
can be represented as ( ) The following corollary shows how to actually design a sinusoidal-type activation function using Theorem 1.
Corollary 1.
Let β be the same as in Equation (2) 
Proof. We can easily derive the following equation, which is the inverse function of Equation (2). 
The following corollary shows that the designed sinusoidaltype activation function guarantees the global exponential stability of the inference process of an FCM. 
≤ . Corollary 2. The inference process of an FCM using Equation (5) is globally exponentially stable when the activation function is a sinusoidal-type, as in Equation (2), where
The sinusoidal-type function of Equation (2) satisfies Assumption 1, and the maximum value of the first derivative of the function occurs when 0 x = . Therefore, the range of β is calculated using inequality (7) and Lemma 3 as follows: 
FCM-based Clinical Decision Making
This guarantees the global exponential stability of Equation (5) . If M = 1 in inequality (13), we finally have ( ) 1.5708 n β ρ ρ = + w , also guarantees the global exponential stability of Equation (5). □ We next give an example that confirms the stability of the inference process using the designed sinusoidal-type activation function. 
0.5 0.7
The (ii) 2 β = 0.8376, which is within the range of β calculated by inequality (14) , and guarantees the global exponential stability of the inference process, 0< β <0.83766392031338.
(iii) 3 β = 1.0870, which is out of the range of β , and does not guarantee the global exponential stability of the inference process. Using the designed sinusoidal-type activation functions, the inferences in Equation (5) Figure 2 shows the designed activation functions and trajectories of the concept values during inference. The results in (i) and (ii) are stable, but some oscillation is observed at the start of the trajectory in the result in (ii), as shown in Figure  2D . Otherwise, the result in (iii) is not stable. Comparing the result in (i) with those in (ii) and (iii), it is reasonable to conclude that this oscillation in the trajectories is caused by the activation functions, which are
, where j∈ {1, 2}.
Design of Linear Activation Functions
A linear function, as shown in Equation (3), is not appropriate for an activation function for inference of FCMs, because it monotonously increases for the domain and range of ( −∞ , ∞ ). However, if we know the domain range of the linear function to be reached during inference process, we can design the linear function as an activation function. That is, the following corollary shows a way to design a linear-type activation function that satisfies the following condition.
Assumption 3. The function :
f → R R is bounded; i.e., 0 ( ) f u M ≤ ≤ for all 1 2 , , u u u ∈R such that 1 2 [ , ] u u u ∈ and 1 2 u u < , and any M ∈R such that 0 M > .
Corollary 3.
Let α be the same as in Equation (3) 
Design of FCM on Pulmonary Infection
To apply he designed sinusoidal-type and linear activation functions to an FCM model for a clinical decision, we refer the FCM model designed in [2] representing causal knowledge of pulmonary infections. However, the characteristics of the FCM in [2] are different with those of the FCM con-In Keun Lee et al sidered in this paper. That is, different from Definition 1, the concept values in [2] were bounded into the interval [-1, 1], and a bipolar activation function was used for the inference process. Therefore, we customize the FCM model designed in [2] , as shown Figure 3 , by adding seven concepts (C26-1, C27-1, C28-1, C29-1, C30-1, C31-1, and C32-1) representing the negative values of the concepts (C26, C27, C28, C29, C30, C31, and C32, respectively), as was done in [11] . We deal with the two scenarios described in [2] . That is, this experiment aims to show the process for physician's decision that which patient is more serious in pulmonary 
III. Results
According to [2] , physicians made decision that the patient in scenario 1 is more serious in pulmonary infection than that in scenario 2, and the inference of FCM also shows the same result with the physicians' decision. In this experiment, therefore, we compared the results of the inference process of the FCMs with four activation functions, (i) the sigmoid function designed in [12] , (ii) a sinusoidal-type function designed using the method proposed in [12] , (iii) a sinusoidaltype function and (iv) a linear function designed using the proposed method. In these inferences, we provided the same stimulus as in [16] .
According to the two scenarios, we created the following initial state vectors: x , and thus the gap between the converged concept values is very small, at
Even though it was difficult to make a decision based on the results in (i), the results showed that the patient in scenario 1 has a severer condition than the patient in scenario 2, which is the same result determined in [2] .
For (ii), the values of concept D1 regarding scenarios 1 and 2 were converged to Figure 4C , the maximum values of
exceeded the value that yielded max ( ) I v . As a result, the patient in scenario 2 has a severer condition than the patient in scenario 1, which is contrary to (i). That is, the result is not useful for decision making. For (iii), the values of concept D1 regarding scenarios 1 and 2 were converged to v v − = 0.0052. As a result, we can see that although the sinusoidal-type activation functions was designed using the method proposed in [12] , it occasionally provides incorrect results for decision making. Therefore, we can determine that the method proposed in this paper is more appropriate for designing sinusoidal-type activation functions than the method proposed in [12] .
IV. Discussion
There exist various methods to support physicians' clinical decision making such as fuzzy, neural networks, decision tree, and FCMs. However, the usability of the methods is strongly dependent on the features of a clinical field; because their knowledge models are different from each other and each method has its own strength and weakness. And even in the same method, the results of decision making may be different according to its knowledge model. Thus, the users in clinical field (e.g., physicians) only refer to the results from the methods when they make clinical decisions. The aim of the methods in clinical field is how clearly shows the results to the users.
In this paper, we focused on a clinical decision making based on FCMs, which are good models of the causal knowledge of relationships between medical concepts and provide prediction results based on the current status of a concept through an inference process. Therefore, activation functions used for the inference process are very important factors that support physicians in making the right decision. In other words, for physicians to make a final decision, how well the physicians' knowledge is represented as an FCM model is not the only important factor. The inference process of that model is also important in the application of clinical decision making. In general, sigmoid functions have been used as activation functions for the inference process of FCMs; the design of an activation function is greatly dependent on the experience of experts because, during inference, the slope varies considerably within the domain range of the function.
Therefore, we proposed a method for designing sinusoidaltype and linear activation functions by calculating the domain range of the activation function to be reached during the inference process of FCMs. Even though sinusoidaltype functions are oscillated and linear functions are monotonously increased within the entire range of the domain, the designed activation functions make the inference stable because the proposed method notices where the function is used in the inference. Moreover, because a sinusoidal-type function designed by the proposed method provides a gentler slope than a sigmoid function does, it can be used as a normalization function. We applied the designed functions to an FCM model that represents the causal knowledge of pulmonary infections. Comparing the activation function designed using the proposed method with activation functions designed using an existing method, we confirmed that the proposed method can be appropriately used for designing the activation functions for the inference process of an FCM for clinical decision making.
This study dealt with only two kinds of functions and limited their adaption into an example of decision making with
